Literature DB >> 805009

Is the primary complement lesion insufficient for lysis? Failure of cells damaged under osmotic protection to lyse in EDTA or at low temperature after removal of osmotic protection.

S J Burakoff, E Martz, B Benacerraf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 805009     DOI： 10.1016/0090-1229(75)90045-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  9 in total

1.  Complement action on secretory cells identified by the reverse hemolytic plaque assay: modified assay eliminates exposure of secretory cells to complement.

Authors:  K A Gregerson
Journal:  Endocrine       Date:  1995-05       Impact factor: 3.633

2.  Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.

Authors:  J C Shivers; C A Daniels
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

3.  Time-dependent resistance or susceptibility of tumor cells to cytotoxic antibody after exposure to a chemotherapeutic agent.

Authors:  P J Leibson; H Schreiber; M R Loken; S Panem; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

Review 4.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

5.  Single channel currents induced by complement in antibody-coated cell membranes.

Authors:  M B Jackson; C L Stephens; H Lecar
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  The use of antibody and complement to gain access to the interior of presynaptic nerve terminals.

Authors:  E S Schweitzer; M P Blaustein
Journal:  Exp Brain Res       Date:  1980       Impact factor: 1.972

7.  Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity.

Authors:  R R Dourmashkin; P Deteix; C B Simone; P Henkart
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

8.  Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.

Authors:  B P Morgan; C A Sewry; K Siddle; J P Luzio; A K Campbell
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

9.  Cytolytic effects of the complement cleavage product, C3a.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.